Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties.
## Primary Indications
* Management of anxiety disorders.
* Short-term relief of insomnia.
* Treatment of status epilepticus.
* Premedication for surgical procedures.
## Adult Dosing
* **Anxiety:** 1 to 2 mg orally every 6 to 8 hours as needed. Doses may range from 1 mg to 10 mg daily.
* **Insomnia:** 2 to 4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg (or 0.1 mg/kg) intravenously or intramuscularly, may be repeated after 10 to 15 minutes, not to exceed 8 mg in a 12-hour period.
* **Premedication:** 2 to 4 mg orally or intramuscularly 1 to 2 hours before surgery, or 1 to 2 mg intravenously 15 to 20 minutes before anesthesia.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be based on weight and clinical condition. Specific dosing recommendations for pediatrics are often determined by institutional protocol or specialist consultation.
* **Status Epilepticus:** 0.1 mg/kg IV/IM, not to exceed 4 mg per dose. May be repeated in 10-15 minutes.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dosage reduction may be necessary.
* **Renal Impairment:** Use with caution; dosage reduction may be necessary.
* **Elderly:** Start with lower doses (e.g., 0.5 mg to 1 mg orally once or twice daily) and titrate cautiously.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
## Adverse Effects
Common adverse effects include drowsiness, dizziness, sedation, weakness, and ataxia. Less common effects include confusion, depression, amnesia, and paradoxical reactions (e.g., excitement, aggression). Respiratory depression can occur, especially with parenteral administration or in combination with other CNS depressants.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, barbiturates, other sedatives):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **Theophylline and Aminophylline:** May decrease the sedative effects of lorazepam.
* **Valproic Acid:** May increase lorazepam levels.
## Monitoring
* Monitor for sedation, respiratory rate, and level of consciousness, especially with parenteral administration or in combination with other CNS depressants.
* Assess for effectiveness in managing anxiety, insomnia, or seizures.
* Observe for signs of dependence or withdrawal if used long-term.
## Clinical Pearls
* Lorazepam has a relatively long half-life, which can contribute to accumulation, especially in the elderly or those with hepatic/renal impairment.
* Avoid abrupt discontinuation of chronic therapy due to the risk of withdrawal symptoms. Tapering of the dose is recommended.
* Intramuscular lorazepam is well-absorbed. Intravenous administration should be slow to minimize respiratory depression and hypotension.
***
*Disclaimer: This information is intended for clinical use and does not replace professional medical advice. Always consult the most current prescribing information and institutional guidelines before administering any medication.*
